Evidence map›Paper›PMID 38592927›Full record

ArticleACS infectious diseases2024

Bioluminescence-Based Determination of Cytosolic Accumulation of Antibiotics in

Rachita Dash, Kadie A Holsinger, Mahendra D Chordia, Mohammad Sharifian Gh, Marcos M Pires

Open access · hybridAbstract read
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rachita DashDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0009-0008-1830-1318
Kadie A HolsingerDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Mahendra D ChordiaDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Mohammad Sharifian GhDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Marcos M PiresDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0000-0002-5676-0725
University of Virginia · US

Funding

Unraveling Bacterial Cell Wall Biosynthesis and Sensing via Synthetic AnalogsR35GM124893 · NIGMS · UNIVERSITY OF VIRGINIA · PI Marcos M. Pires · 2017 to 2026
$3.6M
Structural Determinants of Permeation Barriers in Escherichia coliR01AI178975 · NIAID · UNIVERSITY OF VIRGINIA · PI PIRES, MARCOS M. · 2023 to 2024
$1.2M
NIAID NIH HHS R01 AI178975NIGMS NIH HHS R35 GM124893
6 · The paper itself

Abstract

Antibiotic resistance is an alarming public health concern that affects millions of individuals across the globe each year. A major challenge in the development of effective antibiotics lies in their limited ability to permeate cells, noting that numerous susceptible antibiotic targets reside within the bacterial cytosol. Consequently, improving the cellular permeability is often a key consideration during antibiotic development, underscoring the need for reliable methods to assess the permeability of molecules across cellular membranes. Currently, methods used to measure permeability often fail to discriminate between the arrival within the cytoplasm and the overall association of molecules with the cell. Additionally, these techniques typically possess throughput limitations. In this work, we describe a luciferase-based assay designed for assessing the permeability of molecules in the cytosolic compartment of Gram-negative bacteria. Our findings demonstrate a robust system that can elucidate the kinetics of intracellular antibiotic accumulation in live bacterial cells in real time.

Indexed as

Anti-Bacterial AgentsCytosolEscherichia coliLuminescent MeasurementsCell Membrane PermeabilityMicrobial Sensitivity TestsAnti-Bacterial Agentsantibioticbacterialcellulardrug moleculesmethodspermeability

Identifiers

PMID38592927
PMCPMC11091882
OpenAlexW4394599546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.